| 09/09/26 | 18:00:00 | 9 Sept 2026 | | PRTC's SPTX: New Positive Phase 1 GlyphAllo Data | RNS |
| 04/09/26 | 17:30:00 | 4 Sept 2026 | | Holding(s) in Company | RNS |
| 04/09/26 | 07:00:03 | 4 Sept 2026 | | Notice of Results | RNS |
| 01/09/26 | 07:00:14 | 1 Sept 2026 | | Total Voting Rights | RNS |
| 28/08/26 | 07:00:03 | 28 Aug 2026 | | Holding(s) in Company | RNS |
| 25/08/26 | 12:05:01 | 25 Aug 2026 | | PRTC's Celea:2 Deupirfenidone Presentations at ERS | RNS |
| 03/08/26 | 07:00:04 | 3 Aug 2026 | | Total Voting Rights | RNS |
| 31/07/26 | 17:00:01 | 31 Jul 2026 | | PDMR Notification RSU Vesting | RNS |
| 17/07/26 | 17:00:00 | 17 Jul 2026 | | PDMR Notification RSU Vesting | RNS |
| 13/07/26 | 07:00:10 | 13 Jul 2026 | | PRTC: Celea Doses 1st Patient in Phase 3 IPF Trial | RNS |
| 09/07/26 | 07:00:04 | 9 Jul 2026 | | Director/PDMR Shareholding | RNS |
| 02/07/26 | 07:01:01 | 2 Jul 2026 | | PRTC Launches Celea w/ $180M & Top Tier Syndicate | RNS |
| 02/07/26 | 07:00:03 | 2 Jul 2026 | | PRTC Launches Celea: $180M & Asset Transfer | RNS |
| 10/06/26 | 17:38:37 | 10 Jun 2026 | | Result of AGM | RNS |
| 09/06/26 | 07:00:05 | 9 Jun 2026 | | PRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data | RNS |
| 04/06/26 | 17:37:04 | 4 Jun 2026 | | Holding(s) in Company | RNS |
| 29/05/26 | 17:00:01 | 29 May 2026 | | Holding(s) in Company | RNS |
| 27/05/26 | 17:30:00 | 27 May 2026 | | Holding(s) in Company | RNS |
| 22/05/26 | 17:00:01 | 22 May 2026 | | Holding(s) in Company | RNS |
| 15/05/26 | 07:00:06 | 15 May 2026 | | Correction - Holding(s) in Company | RNS |
| 13/05/26 | 12:00:01 | 13 May 2026 | | PRTC To Showcase Deupirfenidone at ATS Conference | RNS |
| 08/05/26 | 07:00:04 | 8 May 2026 | | Holding(s) in Company | RNS |
| 07/05/26 | 18:27:14 | 7 May 2026 | | Holding(s) in Company | RNS |
| 01/05/26 | 07:00:07 | 1 May 2026 | | PureTech's Seaport Prices Upsized IPO Nasdaq: SPTX | RNS |
| 29/04/26 | 07:01:00 | 29 Apr 2026 | | Final Results | RNS |
| 29/04/26 | 07:00:10 | 29 Apr 2026 | | PRTC Voluntarily Delists Nasdaq Depositary Shares | RNS |
| 27/04/26 | 18:09:15 | 27 Apr 2026 | | Holding(s) in Company | RNS |
| 27/04/26 | 12:05:00 | 27 Apr 2026 | | PRTC's Seaport Adds Neuropsychiatry Veteran to BOD | RNS |
| 24/04/26 | 17:58:40 | 24 Apr 2026 | | Holding(s) in Company | RNS |
| 22/04/26 | 12:00:00 | 22 Apr 2026 | | PRTC's Gallop: Positive Ph1 Topline MDS & AML Data | RNS |
| 16/04/26 | 17:00:00 | 16 Apr 2026 | | Holding(s) in Company | RNS |
| 16/04/26 | 07:00:07 | 16 Apr 2026 | | Holding(s) in Company | RNS |
| 13/04/26 | 07:05:00 | 13 Apr 2026 | | Notice of Results | RNS |
| 13/04/26 | 07:00:09 | 13 Apr 2026 | | PRTC's Seaport Files for Proposed Nasdaq IPO | RNS |
| 02/04/26 | 13:12:38 | 2 Apr 2026 | | PRTC Publishes Phase 2b Deupirfenidone IPF Results | RNS |
| 02/04/26 | 12:03:08 | 2 Apr 2026 | | PRTC's Seaport: Positive Topline Ph1 for GlyphAgo | RNS |
| 01/04/26 | 07:00:07 | 1 Apr 2026 | | Total Voting Rights | RNS |
| 25/03/26 | 18:00:48 | 25 Mar 2026 | | PRTC’s Seaport: GlyphAllo Paper Published | RNS |
| 13/03/26 | 16:35:00 | 13 Mar 2026 | | PDMR Notification RSU Vesting | RNS |
| 02/03/26 | 07:00:05 | 2 Mar 2026 | | Total Voting Rights | RNS |
| 25/02/26 | 07:00:10 | 25 Feb 2026 | | PRTC to Present at Leerink Healthcare Conference | RNS |
| 19/02/26 | 17:15:00 | 19 Feb 2026 | | PRTC's Deupirfenidone Granted FDA & EU ODD for IPF | RNS |
| 06/01/26 | 12:00:00 | 6 Jan 2026 | | PureTech to Present at the JP Morgan Conference | RNS |
| 18/12/25 | 07:00:08 | 18 Dec 2025 | | PureTech Appoints Robert Lyne as CEO | RNS |
| 10/12/25 | 17:41:29 | 10 Dec 2025 | | Results of AGM on June 16, 2025 – Update Statement | RNS |
| 10/12/25 | 17:30:00 | 10 Dec 2025 | | Holding(s) in Company | RNS |
| 08/12/25 | 07:00:11 | 8 Dec 2025 | | PRTC: Successful FDA Meeting; IPF Phase 3 in 1H26 | RNS |
| 05/12/25 | 18:00:00 | 5 Dec 2025 | | PRTC's Gallop: Positive Initial Topline AML Data | RNS |
| 18/11/25 | 17:30:00 | 18 Nov 2025 | | Holding(s) in Company | RNS |
| 07/11/25 | 18:18:30 | 7 Nov 2025 | | Holding(s) in Company | RNS |
